Acorah Software Products - Accounts Production 14.6.300 false true 31 October 2022 1 November 2021 false 1 November 2022 31 October 2023 31 October 2023 5953855 Dr Perminder Dhanjal Mr Malkit Singh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 5953855 2022-10-31 5953855 2023-10-31 5953855 2022-11-01 2023-10-31 5953855 frs-core:CurrentFinancialInstruments 2023-10-31 5953855 frs-core:FurnitureFittings 2023-10-31 5953855 frs-core:FurnitureFittings 2022-11-01 2023-10-31 5953855 frs-core:FurnitureFittings 2022-10-31 5953855 frs-core:ShareCapital 2023-10-31 5953855 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31 5953855 frs-bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 5953855 frs-bus:FilletedAccounts 2022-11-01 2023-10-31 5953855 frs-bus:SmallEntities 2022-11-01 2023-10-31 5953855 frs-bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 5953855 frs-bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 5953855 frs-bus:Director1 2022-11-01 2023-10-31 5953855 frs-bus:Director1 2022-10-31 5953855 frs-bus:Director1 2023-10-31 5953855 frs-bus:CompanySecretary1 2022-11-01 2023-10-31 5953855 frs-countries:EnglandWales 2022-11-01 2023-10-31 5953855 2021-10-31 5953855 2022-10-31 5953855 2021-11-01 2022-10-31 5953855 frs-core:CurrentFinancialInstruments 2022-10-31 5953855 frs-core:ShareCapital 2022-10-31 5953855 frs-core:RetainedEarningsAccumulatedLosses 2022-10-31
Registered number: 5953855
PKD CLINICAL RESEARCH LIMITED
Unaudited Financial Statements
For The Year Ended 31 October 2023
Evans & Evans Ltd
24A St Radigunds Road
Dover
Kent
CT17 0JY
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 5953855
2023 2022
Notes £ £ £ £
FIXED ASSETS
CURRENT ASSETS
Debtors 5 5,200 -
Cash at bank and in hand 299,122 299,122
304,322 299,122
Creditors: Amounts Falling Due Within One Year 6 (193 ) (1,014 )
NET CURRENT ASSETS (LIABILITIES) 304,129 298,108
TOTAL ASSETS LESS CURRENT LIABILITIES 304,129 298,108
NET ASSETS 304,129 298,108
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account 304,029 298,008
SHAREHOLDERS' FUNDS 304,129 298,108
Page 1
Page 2
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Perminder Dhanjal
Director
20 July 2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
PKD CLINICAL RESEARCH LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 5953855 . The registered office is 10 STONEHAVEN ROAD, RUSHEY MEAD , LEICESTER, LE4 7PR.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 15% Reducing Balance
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
1 1
4. Tangible Assets
Fixtures & Fittings
£
Cost
As at 1 November 2022 3,223
As at 31 October 2023 3,223
Depreciation
As at 1 November 2022 3,223
As at 31 October 2023 3,223
Net Book Value
As at 31 October 2023 -
As at 1 November 2022 -
5. Debtors
2023 2022
£ £
Due within one year
Director's loan account 5,200 -
Page 3
Page 4
6. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Trade creditors 193 746
Director's loan account - 268
193 1,014
7. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 100 100
8. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 November 2022 Amounts advanced Amounts repaid Amounts written off As at 31 October 2023
£ £ £ £ £
Dr Perminder Dhanjal - 5,200 - - 5,200
The above loan is unsecured, interest free and repayable on demand. This is cleared within 9 months of the Company year end 
Page 4